The ADAM12 is upregulated in synovitis and postinflammatory fibrosis of the synovial membrane in patients with early radiographic osteoarthritis

Joint Bone Spine

Volumn 81, Issue 1, 2014, Pages 51-56

  Kerna, Irina ^a   Kisand, Kalle ^a   Suutre, Siim ^a   Murde, Maret ^b   Tamm, Ann ^a   Kumm, Jaanika ^a   Tamm, Agu ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

ADAM12; Gene expression; Knee osteoarthritis; Synovitis

Indexed keywords

ADAM PROTEIN; MESSENGER RNA; PROTEIN ADAM12 B; PROTEIN ADAM12 L; PROTEIN ADAM12 S; UNCLASSIFIED DRUG; ADAM 12 PROTEIN; MEMBRANE PROTEIN; ANTIBODY; DISINTEGRIN AND METALLOPROTEINASE DOMAIN CONTAINING PROTEIN 12;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIBROBLAST; FIBROSIS; GENE EXPRESSION; GENETIC VARIABILITY; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JOINT BIOPSY; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MACROPHAGE; MALE; MIDDLE AGED; PROTEIN EXPRESSION; SYNOVITIS; SYNOVIUM; UPREGULATION; BIOSYNTHESIS; METABOLISM; PATHOLOGY; RADIOGRAPHY; CLINICAL ASSESSMENT; CLINICAL FEATURE; GENE EXPRESSION ASSAY; HISTOPATHOLOGY; HUMAN TISSUE; KNEE ARTHROSCOPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; SYNOVIAL POSTINFLAMMATORY FIBROSIS;

ADAM PROTEINS; ADULT; FEMALE; FIBROSIS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOARTHRITIS, KNEE; RNA, MESSENGER; SYNOVIAL MEMBRANE; SYNOVITIS; UP-REGULATION;

EID: 84893721060     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.03.007     Document Type: Article

References (38)

1. Smith M.M., Cake M.A., Ghosh P., et al. Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy. Rheumatology 2008, 47:1172-1178.
2. Sandell L.J., Aigner T. Articular cartilage and changes in arthritis an introduction: cell biology of osteoarthritis. Arthritis Res 2001, 3:107-113.
3. Fernandez-Madrid F., Karvonen R.L., Teitge R.A., et al. Synovial thickening detected by MR imaging in osteoarthritis of the knee confirmed by biopsy as synovitis. Magn Reson Imaging 1995, 13:177-183.
4. Benito M.J., Veale D.J., Fitz Gerald O., et al. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005, 64:1263-1267.
5. Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010, 6:625-635.
6. Scanzello C.R., McKeon B., Swaim B.H., et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum 2011, 63:391-400.
7. Rollín R., Marco F., Jover J.A., et al. Early lymphocyte activation in the synovial microenvironment in patients with osteoarthritis: comparison with rheumatoid arthritis patients and healthy controls. Rheumatol Int 2008, 28:757-764.
8. Attur M.G., Dave M., Akamatsu M., et al. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 2002, 10:1-4.
9. Edwards J.C. Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis. Arthritis Res 2000, 2:344-347.
10. Steenvoorden M.M., Tolboom T.C., van der Pluijm G., et al. Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Arthritis Res Ther 2006, 8:R165.
11. Gobezie R., Kho A., Krastins B., et al. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 2007, 9:R36.
12. Aigner T., Soeder S., Haag J. IL-1beta and BMPs - interactive players of cartilage matrix degradation and regeneration. Eur Cell Mater 2006, 12:49-56.
13. Okada A., Mochizuki S., Yatabe T., et al. ADAM-12 (meltrin alpha) is involved in chondrocyte proliferation via cleavage of nsulin-like growth factor binding protein 5 in osteoarthritic cartilage. Arthritis Rheum 2008, 58:778-789.
14. Valdes A.M., Van Oene M., Hart D.J., et al. Reproducible genetic associations between candidate genes and clinical knee steoarthritis in men and women. Arthritis Rheum 2006, 54:533-539.
15. Valdes A.M., Hart D.J., Jones K.A., et al. Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Arthritis Rheum 2004, 50:2497-2507.
16. Kerna I., Kisand, Tamm A.E., et al. Missense single ucleotide polymorphism of the ADAM12 gene is associated with radiographic knee steoarthritis in middle-aged Estonian cohort. Osteoarthritis Cartilage 2009, 17:1093-1098.
17. Limer K.L., Tosh K., Bujac S., et al. Attempt to replicate published genetic associations in a large, well-defined osteoarthritis case-control population (the GOAL study). Osteoarthritis Cartilage 2009, 17:782-789.
18. Shin M.H., Lee S.J., Kee S.J., et al. Genetic association analysis of GDF5 and ADAM12 for knee osteoarthritis. Joint Bone Spine 2012, 79:488-491.
19. Wewer U., Albrechtsen R., Engvall E. ADAM12: the long and the short of it. The ADAM family of proteases 2005, Springer, Dordrecht, the Netherlands. N.M. Hooper, J.D. Leonard (Eds.).
20. Loechel F., Fox J.W., Murphy G., et al. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 2000, 278:511-515.
21. Thodeti C.K., Frohlich C., Nielsen C.K., et al. ADAM12-mediated focal adhesion formation is differently regulated by beta1 and beta3 integrins. FEBS Lett 2005, 579:5589-5595.
22. Iba K., Albrechtsen R., Gilpin B.J., et al. Cysteinerich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol 1999, 154:1489-1501.
23. Arribas J., Bech-Serra J.J., Santiago-Josefat B. ADAMs, cell migration and cancer. Cancer Metastasis Rev 2006, 25:57-68.
24. Laigaard J., Sørensen T., Fröhlich C., et al. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn 2003, 23:1086-1091.
25. Komiya K., Enomoto H., Inoki I., et al. Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis. Arthritis Res Ther 2005, 7:R1158-R1173.
26. Nagaosa Y., Mateus M., Hassan B., et al. Development of logically devised line drawing atlas for grading of knee osteoarthritis. Ann Rheum Dis 2000, 59:587-595.
27. TaqMan® Gene Expression Assays Protocol, Assessed on 18.04.2011. http://www3.appliedbiosystems.com/cms/groups/mcb_support/documents/generaldocuments/cms_041280.pdf.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
29. Loeuille D., Chary-Valckenaere I., Champigneulle J., et al. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. Arthritis Rheum 2005, 52:3492-3501.
30. Haywood L., McWilliams D.F., Pearson C.I., et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003, 48:2173-2177.
31. Hayashi D., Roemer F.W., Katur A., et al. Imaging of synovitis in osteoarthritis: current status and outlook. Semin Arthritis Rheum 2011, 41:116-130.
32. AtturF M., Samuels J., Krasnokutsky S., et al. Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence?. Best Pract Res Clin Rheumatol 2010, 24:71-79.
33. Kraus V.B., Burnett B., Coindreau J., et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage 2011, 19:515-542.
34. Gilpin B.J., Loechel F., Mattei M.G., et al. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 1998, 273:57-66.
35. Jørgensen L.H., Jensen C.H., Wewer U.M., et al. Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx mice. Am J Pathol 2007, 171:1599-1607.
36. Chujo S., Shirasaki F., Kawara S., et al. Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor-β in a mouse fibrosis model. J Cell Physiol 2005, 203:447-456.
37. WO/2011/024146. Adam12 inhibitors and their use against inflammation-induced fibrosis. International Application No.: PCT/IB2010/053865. Inventors: Peduto L, Eberl G. Assessed on 10.01.2012. http://www.wipo.int/pctdb/en/wo.jsp%3FWO=2011024146.
38. Sivakumar P., Das A.M. Fibrosis, chronic inflammation and new pathways for drug discovery. Inflamm Res 2008, 57:410-418.